Phathom Pharmaceuticals (PHAT) Invested Capital (2019 - 2021)
Phathom Pharmaceuticals (PHAT) posted quarterly Invested Capital of $10.3 million for Q2 2021, up 644.78% year-over-year from $1.4 million in Q2 2020, and down 12.07% quarter-over-quarter from $11.8 million in Q1 2021.
Phathom Pharmaceuticals (PHAT) Invested Capital (2019 - 2021) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has reported Invested Capital for 3 consecutive years, with $10.3 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Invested Capital rose 644.78% year-over-year to $10.3 million; the TTM figure through Mar 2022 stood at $10.3 million (down 60.31% YoY), while the FY2020 annual figure was $7.4 million, down 70.59% from the prior year.
- Invested Capital eased to $10.3 million in Q2 2021 per PHAT's latest filing, from $11.8 million in the prior quarter.
- Across five years, Invested Capital topped out at $50.0 million in Q1 2020 and bottomed at $1.4 million in Q2 2020.
- Historically, Invested Capital has averaged $17.1 million across 3 years, with a median of $11.1 million in 2021.
- Annual changes were most pronounced in 2020 — Invested Capital tumbled 77.78% — and 2021, when it jumped 644.78%.
- Phathom Pharmaceuticals' Invested Capital stood at $25.0 million in 2019, then plunged by 70.59% to $7.4 million in 2020, then jumped by 40.69% to $10.3 million in 2021.
- Business Quant data shows PHAT's Invested Capital at $10.3 million in Q2 2021, $11.8 million in Q1 2021, and $7.4 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Phathom Pharmaceuticals | 767.07 Mn | 581.73 Mn | 59.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 10.35 Mn |
| Mar 31, 2021 | 11.77 Mn |
| Dec 31, 2020 | 7.35 Mn |
| Sep 30, 2020 | 5.56 Mn |
| Jun 30, 2020 | 1.39 Mn |
| Mar 31, 2020 | 50.00 Mn |
| Dec 31, 2019 | 25.00 Mn |
| Sep 30, 2019 | 25.00 Mn |